ES514359A0 - Un procedimiento para la preparacion de derivados de imidazolina. - Google Patents

Un procedimiento para la preparacion de derivados de imidazolina.

Info

Publication number
ES514359A0
ES514359A0 ES514359A ES514359A ES514359A0 ES 514359 A0 ES514359 A0 ES 514359A0 ES 514359 A ES514359 A ES 514359A ES 514359 A ES514359 A ES 514359A ES 514359 A0 ES514359 A0 ES 514359A0
Authority
ES
Spain
Prior art keywords
preparation
imidazoline derivatives
hydrogen
procedure
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514359A
Other languages
English (en)
Other versions
ES8307796A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Publication of ES514359A0 publication Critical patent/ES514359A0/es
Publication of ES8307796A1 publication Critical patent/ES8307796A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
ES514359A 1981-07-28 1982-07-26 Un procedimiento para la preparacion de derivados de imidazolina. Expired ES8307796A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8123271 1981-07-28

Publications (2)

Publication Number Publication Date
ES514359A0 true ES514359A0 (es) 1983-08-01
ES8307796A1 ES8307796A1 (es) 1983-08-01

Family

ID=10523561

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514359A Expired ES8307796A1 (es) 1981-07-28 1982-07-26 Un procedimiento para la preparacion de derivados de imidazolina.

Country Status (24)

Country Link
US (1) US4411908A (es)
EP (1) EP0071368B1 (es)
JP (1) JPS5826884A (es)
AT (1) ATE12769T1 (es)
AU (1) AU549166B2 (es)
CA (1) CA1171864A (es)
CS (1) CS229938B2 (es)
DD (1) DD211349A5 (es)
DE (1) DE3263123D1 (es)
DK (1) DK160275C (es)
ES (1) ES8307796A1 (es)
FI (1) FI67545C (es)
GR (1) GR76210B (es)
HU (1) HU190023B (es)
IE (1) IE53389B1 (es)
IL (1) IL66353A (es)
NO (1) NO157215C (es)
NZ (1) NZ201219A (es)
PH (1) PH18878A (es)
PL (1) PL139439B1 (es)
PT (1) PT75329B (es)
SU (1) SU1204134A3 (es)
ZA (1) ZA825164B (es)
ZW (1) ZW13782A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539415B1 (fr) * 1983-01-14 1985-09-13 Adir Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
DE3465993D1 (en) * 1983-08-11 1987-10-15 Synthelabo Indole derivatives, their preparation and their therapeutical application
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
KR910005851B1 (ko) * 1983-12-12 1991-08-05 신 떼라보 피롤로[3,2,1-hi]인돌유도체 및 약학적으로 허용되는 그의 산부가염을 제조하는 방법
FR2621486B1 (fr) * 1987-10-07 1990-01-26 Synthelabo Utilisation de derives de pyrrolo(3,2,1-hi)indole pour obtenir un medicament destine au traitement du diabete
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
CA1260947A (en) * 1984-12-29 1989-09-26 Yoshitaka Ohishi Benzofuran derivative, process for preparing the same and pharmaceutical composition containing the same
US4895867A (en) * 1986-06-26 1990-01-23 Norwich Eaton Pharmaceuticals, Inc. 2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
DK344489D0 (da) * 1989-07-12 1989-07-12 Novo Nordisk As Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives
FR2706303B1 (fr) * 1993-06-18 1995-09-08 Pf Medicament Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
FR2707166B1 (fr) * 1993-07-09 1995-09-29 Pf Medicament Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
ZA9811672B (en) * 1997-12-19 2000-06-19 Lilly Co Eli Hypoglycemic imidazoline compounds.
FR2784989B1 (fr) * 1998-09-10 2002-09-27 Fabre Pierre Sante Derive d'ester d'acide 2-ethyl-2,3-dihydrobenzofurane- carboxylique, procede de preparation et utilisation pour la preparation de derives de l'efaroxan
AU5319700A (en) * 1999-06-02 2000-12-18 S. Mbua Ngale Efange Nicotine receptor ligands
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168216A1 (en) * 1972-01-21 1973-08-31 Labaz Substd imidazolines - with vasoconstrictor activity
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
DE2933962A1 (de) * 1979-08-22 1981-03-26 Hoechst Ag, 65929 Frankfurt Verfahren zur herstellung von 4,5-dichlor-imidazolen.

Also Published As

Publication number Publication date
AU8643882A (en) 1983-06-02
HU190023B (en) 1986-08-28
IL66353A (en) 1985-08-30
NZ201219A (en) 1984-10-19
DK335682A (da) 1983-01-29
PH18878A (en) 1985-10-22
JPS5826884A (ja) 1983-02-17
IL66353A0 (en) 1982-11-30
ZW13782A1 (en) 1982-10-06
CA1171864A (en) 1984-07-31
DD211349A5 (de) 1984-07-11
IE53389B1 (en) 1988-10-26
NO822568L (no) 1983-01-31
PT75329B (en) 1984-07-31
ZA825164B (en) 1983-05-25
JPH0233038B2 (es) 1990-07-25
US4411908A (en) 1983-10-25
ES8307796A1 (es) 1983-08-01
FI67545C (fi) 1985-04-10
FI822551A0 (fi) 1982-07-20
EP0071368B1 (en) 1985-04-17
CS229938B2 (en) 1984-07-16
AU549166B2 (en) 1986-01-16
IE821789L (en) 1983-01-28
DE3263123D1 (de) 1985-05-23
PL237655A1 (en) 1983-03-28
ATE12769T1 (de) 1985-05-15
PT75329A (en) 1982-08-01
EP0071368A1 (en) 1983-02-09
NO157215C (no) 1988-02-10
DK160275C (da) 1991-07-22
PL139439B1 (en) 1987-01-31
FI822551L (fi) 1983-01-29
FI67545B (fi) 1984-12-31
SU1204134A3 (ru) 1986-01-07
GR76210B (es) 1984-08-03
NO157215B (no) 1987-11-02
DK160275B (da) 1991-02-18

Similar Documents

Publication Publication Date Title
ES514359A0 (es) Un procedimiento para la preparacion de derivados de imidazolina.
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
ES532149A0 (es) Procedimiento para la preparacion de nuevos compuestos fluoroalcoxilicos
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
ES504206A0 (es) Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
SE7709158L (sv) Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
ATE15370T1 (de) 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel.
DK160093C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolderivater
ES557201A0 (es) Procedimiento para la obtencion de piridazinonas sustituidas
MX5687E (es) Procedimiento para la preparacion de derivados imidazo(1,2-alpha)-imidazol substituidos
ES497948A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas
MC1421A1 (fr) Derives acyles
ES515201A0 (es) "procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
TH2974EX (th) อนุพันธ์ควิโนโลนคาร์บอกซิลิคแอซิด
ES527550A0 (es) Procedimiento para la preparacion de derivados de acridanona